Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 11, 2015
Assessment of Simplified Blood Dose Protocols for the Estimation of the Maximum Tolerable Activity in Thyroid Cancer Patients Undergoing Radioiodine Therapy Using 124IWalter Jentzen, Andreas Bockisch, Marcus Ruhlmann
Nuklearmedizin. Nuclear Medicine|February 3, 2016
Initial [18F]FDG PET/CT in high-risk DTC patients. A three-year follow-upMarcus Ruhlmann, Ina Binse, Andreas Bockisch, et al.
Acta Radiologica Open|April 30, 2015
A single-center experience in radioembolization as salvage therapy of hepatic metastases of uveal melanomaJuliane Schelhorn, Heike Richly, Marcus Ruhlmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 7, 2016
High Level of Agreement Between Pretherapeutic 124I PET and Intratherapeutic 131I Imaging in Detecting Iodine-Positive Thyroid Cancer MetastasesMarcus Ruhlmann, Walter Jentzen, Verena Ruhlmann, et al.
European Journal of Radiology|October 26, 2016
Hybrid imaging for detection of carcinoma of unknown primary: A preliminary comparison trial of whole-body PET/MRI versus PET/CTVerena Ruhlmann, Marcus Ruhlmann, Alexander Bellendorf, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 17, 2015
Impact of Point-Spread Function Modeling on PET Image Quality in Integrated PET/MR Hybrid ImagingBassim Aklan, Mark Oehmigen, Karsten Beiderwellen, et al.
Pageof 2